on 06 Dec 2022
Last Applicant/ Owned by
Experimental Station E400/3213
Wilmington
DE
198032907
Serial Number
88454877 filed on 31st May 2019
Registration Number
6918641 registered on 06th Dec 2022
Correspondent Address
Lisa Bollinger Gehman
Filing Basis
1. intent to use
2. use application currently
Disclaimer
"THERAPEUTICS"
Color is not claimed as a feature of the mark. "THERAPEUTICS" The mark consists of a series of DNA strands formed into an eight-pointed star shaped design, to the right of the design appears the word "PRELUDE" having the first letter capitalized and the word "THERAPEUTICS" in smaller capital block letters centered below "PRELUDE.". Research and development of drugs in the fields of oncology, heRead More
Research and development of drugs in the fields of oncology, hematology, autoimmune diseases, and rare diseases; scientific research for medical purposes in the fields of oncology, hematology, autoimmune diseases, and rare diseases; clinical research in the fields of oncology, hematology, autoimmune diseases, and rare diseases; scientific research and development of pharmaceuticals and biopharmaceuticals for the treatment of cancer, hematological diseases, autoimmune diseases, and rare diseases; providing websites featuring medical and scientific research information about pharmaceutical and biopharmaceutical drugs and their preparations; genetic testing for scientific research; genetic research in the fields of oncology, hematology, autoimmune diseases, and rare diseases; none of the foregoing in relation to or in the field of fertility
20th Apr 2017
20th Apr 2017
No 88454877
No Service Mark
No 105807.00502
No
No
No
No
No
No
No
No
26.01.28 -
Miscellaneous circular designs with an irregular circumference
26.01.29 -
Helixes
The mark consists of a series of DNA strands formed into an eight-pointed star shaped design, to the right of the design appears the word "PRELUDE" having the first letter capitalized and the word "THERAPEUTICS" in smaller capital block letters centered below "PRELUDE.".
| Status Date | Action Taken |
|---|---|
| 06th Dec 2022 | REGISTERED-PRINCIPAL REGISTER |
| 06th Dec 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 01st Nov 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 31st Oct 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 12th Oct 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 12th Oct 2022 | STATEMENT OF USE PROCESSING COMPLETE |
| 29th Sep 2022 | USE AMENDMENT FILED |
| 29th Sep 2022 | TEAS STATEMENT OF USE RECEIVED |
| 10th May 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 15th Mar 2022 | PUBLISHED FOR OPPOSITION |
